Join us Dec. 1-3 in Nashville for the Digiday Programmatic Marketing Summit
Mushroom boardroom: Why some execs are using psychedelics to get through the workday
This is a preview of a story that was initially published on our sister site, WorkLife, which covers the future of the workplace.
After his father died in 2018, Paul Marlow struggled with fear, anxiety and depression. That’s when he turned to microdosing psychedelics as a remedy — and he hasn’t looked back.
Microdosing, he said, helps him focus at work. As the pandemic persists, many who are looking for a jolt of motivation, inspiration or medication are turning to microdosing — that is, ingesting small amounts of psychedelic drugs to combat mental health issues and enhance creativity, productivity and physical well-being. Read the full story on WorkLife.
More in Marketing
Mars wants to future proof impulse buys as AI is poised to take over more grocery runs
Mars readies for AI grocery agents by chasing LLM visibility and immersive stores as impulse buys shift. See what’s at stake.
TikTok Shop launches a paid premium tier for 1M of its top U.S. shoppers
TikTok Shop is offering the shopping service to more than 1 million people it has identified as its most loyal U.S. customers.
OpenAI’s new business agents give brands a free way into the conversation it’s also selling as an ad
OpenAI is giving brands a free route into ChatGPT conversations through business agents, but keeping control of the data and recommendations.